News Pfizer will have to cut price of AML drug Mylotarg after NIC... NICE blocks access to 65% of patients on cost grounds
Partner Content Partner Content Jayne Hurrell joins OPEN Access Consulting as Director of Gl... Jayne Hurrell joins OPEN Access Consulting as Director
Partner Content Partner Content Matt De Gruchy joins Reynolds Mackenzie as new agency CEO Matt De Gruchy joins Reynolds Mackenzie as new CEO
Partner Content Partner Content Neil Levinson joins ACCRETIO as Strategy Director Neil Levinson joins ACCRETIO as Strategy Director
News Novartis/Amgen's migraine drug hits market at lower than exp... The FDA has approved the first in a new class of migraine drugs, Novartis and Amgen’s Aimovig, and at a lower than expected list price of $6,900.
News Trump drug price plan attacks 'global freeloaders' Donald Trump made great play about his plans to take on big pharma during his presidential campaign – but his plan to cut drug prices has pleased investors and angered those calling for tou
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
